Keap1-Knockdown Decreases Fasting-Induced Fatty Liver via Altered Lipid Metabolism and Decreased Fatty Acid Mobilization from Adipose Tissue

2010, Vital signs: state-specific obesity prevalence among adults --- United States, 2009, MMWR Morb Mortal Wkly Rep, 59, 951

PM Nilsson, 2008, Is weight loss beneficial for reduction of morbidity and mortality? What is the controversy about?, Diabetes Care, 31, S278, 10.2337/dc08-s268

T Berentzen, 2006, Effects of intended weight loss on morbidity and mortality: possible explanations of controversial results, Nutr Rev, 64, 502, 10.1111/j.1753-4887.2006.tb00183.x

S Kersten, 1999, Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting, J Clin Invest, 103, 1489, 10.1172/JCI6223

S Mandard, 2004, Peroxisome proliferator-activated receptor alpha target genes, Cell Mol Life Sci, 61, 393, 10.1007/s00018-003-3216-3

T Goto, 2011, Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes, J Lipid Res, 52, 873, 10.1194/jlr.M011320

K Rouvinen-Watt, 2010, Rapid development of fasting-induced hepatic lipidosis in the American mink (Neovison vison): effects of food deprivation and re-alimentation on body fat depots, tissue fatty acid profiles, hematology and endocrinology, Lipids, 45, 111, 10.1007/s11745-009-3377-4

HP Guan, 2009, Accelerated fatty acid oxidation in muscle averts fasting-induced hepatic steatosis in SJL/J mice, J Biol Chem, 284, 24644, 10.1074/jbc.M109.034397

P Angulo, 2002, Nonalcoholic fatty liver disease, N Engl J Med, 346, 1221, 10.1056/NEJMra011775

MW Bradbury, 2006, Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis, Am J Physiol Gastrointest Liver Physiol, 290, G194, 10.1152/ajpgi.00413.2005

JF Glatz, 2010, Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease, Physiol Rev, 90, 367, 10.1152/physrev.00003.2009

ME Miquilena-Colina, 2011, Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C, Gut, 60, 1394, 10.1136/gut.2010.222844

A Falcon, 2010, FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase, Am J Physiol Endocrinol Metab, 299, E384, 10.1152/ajpendo.00226.2010

B Hubbard, 2006, Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity, Gastroenterology, 130, 1259, 10.1053/j.gastro.2006.02.012

K Itoh, 1999, Regulatory mechanisms of cellular response to oxidative stress, Free Radic Res, 31, 319, 10.1080/10715769900300881

CD Klaassen, 2010, Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver, Toxicol Appl Pharmacol, 244, 57, 10.1016/j.taap.2010.01.013

H Okawa, 2006, Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity, Biochem Biophys Res Commun, 339, 79, 10.1016/j.bbrc.2005.10.185

YK Zhang, 2010, Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet, Toxicol Appl Pharmacol, 245, 326, 10.1016/j.taap.2010.03.016

MS Yates, 2009, Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice, Carcinogenesis, 30, 1024, 10.1093/carcin/bgp100

DV Chartoumpekis, 2012, Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice, Diabetes, 60, 2465, 10.2337/db11-0112

J Pi, 2010, Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity, J Biol Chem, 285, 9292, 10.1074/jbc.M109.093955

J Xu, 2012, UDP-glucuronosyltransferase expression in mouse liver is increased in obesity- and fasting-induced steatosis, Drug Metab Dispos, 40, 259, 10.1124/dmd.111.039925

J Shao, 2000, Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice, J Endocrinol, 167, 107, 10.1677/joe.0.1670107

J Xu, 2012, Enhanced nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice, Diabetes, 61, 3208, 10.2337/db11-1716

D Patsouris, 2006, Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression, Endocrinology, 147, 1508, 10.1210/en.2005-1132

S Dharancy, 2005, Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection, Gastroenterology, 128, 334, 10.1053/j.gastro.2004.11.016

RJ Shaw, 2005, The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin, Science, 310, 1642, 10.1126/science.1120781

M Kazantzis, 2012, Fatty acid transport proteins, implications in physiology and disease, Biochim Biophys Acta, 1821, 852, 10.1016/j.bbalip.2011.09.010

ME Rinella, 2008, Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet, J Lipid Res, 49, 1068, 10.1194/jlr.M800042-JLR200

MD Jensen, 1987, Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine, J Clin Invest, 79, 207, 10.1172/JCI112785

A Purushotham, 2009, Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation, Cell Metab, 9, 327, 10.1016/j.cmet.2009.02.006

H Liang, 2006, PGC-1alpha: a key regulator of energy metabolism, Adv Physiol Educ, 30, 145, 10.1152/advan.00052.2006

L Zhang, 2010, Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle, Biochim Biophys Acta, 1801, 1, 10.1016/j.bbalip.2009.09.014

VR More, 2013, Keap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feeding, Free Radic Biol Med, 61C, 85, 10.1016/j.freeradbiomed.2013.03.007

Z Yu, 2011, Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice, Diabetologia, 54, 922, 10.1007/s00125-010-2001-8

S Shin, 2009, Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide, Eur J Pharmacol, 620, 138, 10.1016/j.ejphar.2009.08.022

Y Tanaka, 2008, NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet, J Pharmacol Exp Ther, 325, 655, 10.1124/jpet.107.135822

DV Chartoumpekis, 2011, Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice, Diabetes, 60, 2465, 10.2337/db11-0112

SH Choi, 2011, Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance, Trends Endocrinol Metab, 22, 353, 10.1016/j.tem.2011.04.007

K Morgan, 2008, Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease, Eur J Gastroenterol Hepatol, 20, 843, 10.1097/MEG.0b013e3282f9b203

CT Coburn, 2000, Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice, J Biol Chem, 275, 32523, 10.1074/jbc.M003826200

K Gertow, 2004, Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance, Diabetologia, 47, 1118, 10.1007/s00125-004-1417-4

D Hirsch, 1998, A family of fatty acid transporters conserved from mycobacterium to man, Proc Natl Acad Sci U S A, 95, 8625, 10.1073/pnas.95.15.8625

W Stremmel, 1985, Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes, Proc Natl Acad Sci U S A, 82, 4, 10.1073/pnas.82.1.4

W Schwieterman, 1988, Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut, Proc Natl Acad Sci U S A, 85, 359, 10.1073/pnas.85.2.359

DP Koonen, 2007, Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity, Diabetes, 56, 2863, 10.2337/db07-0907

J Krammer, 2011, Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells., Int J Med Sci, 8, 599, 10.7150/ijms.8.599

JP Hardwick, 2009, PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease, PPAR Res, 2009, 2009

C Le May, 2000, Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression, EBS Lett F, 475, 163, 10.1016/S0014-5793(00)01648-3

DM Muoio, 2002, Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells, Diabetes, 51, 901, 10.2337/diabetes.51.4.901

JC Fruchart, 1999, Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis, Curr Opin Lipidol, 10, 245, 10.1097/00041433-199906000-00007

G Martin, 1997, Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators, J Biol Chem, 272, 28210, 10.1074/jbc.272.45.28210

K Motojima, 1998, Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner, J Biol Chem, 273, 16710, 10.1074/jbc.273.27.16710

G Medina-Gomez, 2007, PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism, PLOS Genet, 3, e64, 10.1371/journal.pgen.0030064

D Stapleton, 1997, AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location, FEBS Lett, 409, 452, 10.1016/S0014-5793(97)00569-3

B Viollet, 2009, AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives., Acta Physiol (Oxf), 196, 81, 10.1111/j.1748-1716.2009.01970.x

B Viollet, 2006, Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders., J Physiol, 574, 41, 10.1113/jphysiol.2006.108506

JA Ibdah, 2005, Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance., Gastroenterology, 128, 1381, 10.1053/j.gastro.2005.02.001

I Guillet-Deniau, 2002, Sterol regulatory element binding protein-1c expression and action in rat muscles: insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression., Diabetes, 51, 1722, 10.2337/diabetes.51.6.1722

U Kintscher, 2005, PPARgamma-mediated insulin sensitization: the importance of fat versus muscle., Am J Physiol Endocrinol Metab, 288, E291, 10.1152/ajpendo.00440.2004

N Saraf, 2012, Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization., J Pharm Pharmacol, 64, 161, 10.1111/j.2042-7158.2011.01366.x

SS Im, 2006, Regulation of GLUT4 gene expression by SREBP-1c in adipocytes., Biochem J, 399, 131, 10.1042/BJ20060696

S Huang, 2007, The GLUT4 glucose transporter., Cell Metab, 5, 237, 10.1016/j.cmet.2007.03.006